Since all the recalls, there has not been much of this around to say the least so the new owner in Baltimore will be moving production to a new factory as the J and J facility is still closed down for repairs and upgrades. Here was the announcement from July of 2010.
Johnson and Johnson (McNeil) Lays Off 300 Employees and Will Re-Tool the Tylenol Factory
Recalls of both medical devices and drugs are growing for a number of reasons. First of all, we have a lot more information available today than what we have ever had and we need to capitalize on this opportunity quickly. We read in the news every day it seems about quality control issues, devices needing software updates and so on. How do we get the word out quickly and efficiently? If one has times they can certainly search the web and put out a full on effort to find all of this every day, but healthcare workers have the same problems we all have and that is time. When human lives are involved, time is everything. 
The opportunity to turn a cell phone into a “scanner” with real time information is huge. As mentioned above, this can be a daunting task at times and we have people at all different stages with using technology today and in my opinion, using a cell phone makes sense, when all one has to do is open a program on the phone and simply “shoot and aim” and relative information would be available instantly. Back in October of 2009 I kept reading about all the recalls of devices and created my first opinion/idea post here. It just made sense to me. BD
Johnson & Johnson sold its St. Joseph's aspirin brand to a closely held Baltimore company for an undisclosed sum, the companies said Thursday.
St. Joseph's had been an iconic children's medicine before aspirin use in kids fell out of favor. J&J bought the brand from Schering-Plough Corp. in 2000, and tried to revive the medicine by appealing to baby boomers at risk of heart attack. Yet St. Joseph's couldn't top Bayer's market-leading aspirin, and sales didn't get big enough for J&J to reveal them in financial statements.
Ilex Consumer Products Group Inc. bought the U.S. rights to the brand. Ilex, which sells Calgon and other bath and beauty products, plans to move St. Joseph's production to another plant and expects shipments to retailers to start sometime this spring, according to a spokeswoman for the company, which is owned by Ilex Capital Group LLC, a private investment firm.
big business has always toppled the little guys
ReplyDelete